Kennedy Keith 4
Research Summary
AI-generated summary
CareDx (CDNA) CFO/COO Keith Kennedy Receives RSU Award
What Happened
- Keith Kennedy, Chief Financial Officer and Chief Operating Officer of CareDx, received a grant of 24,134 restricted stock units (RSUs) reported on 2026-04-20. The reported acquisition price is $0 (award). These RSUs do not represent immediately vested shares and will convert to common stock only as they vest.
Key Details
- Transaction date: 2026-04-20; Form 4 filed 2026-04-22 (timely filing).
- Type: Award/Grant (code A); acquisition price: $0.
- Shares reported: 24,134 RSUs granted.
- Shares owned after transaction: not specified in the filing.
- Footnote: RSUs vest one-third on April 6, 2027, with the remaining two-thirds vesting in equal quarterly installments over the next eight quarters (rounded down to whole shares), resulting in 100% vesting by the third anniversary of April 6, 2027 (i.e., April 6, 2030), subject to continuous employment.
- No tax withholding, 10b5-1 plan, or immediate sale noted in the filing.
Context
- RSUs are a form of equity compensation that convert into shares only when they vest; this grant does not indicate an immediate market transaction. Such awards are common for executive compensation and align pay with future service and company performance.